Member Info for Mraveragetrader

It was only a matter of time for this to climb up. The pump and dump circus will be here anytime soon.

I can't wait for positive news to start coming through this summer, hopefully good news for all shareholders, it's been a long long time coming :-).

He's definitely all in on GDR, hopefully this is going to climb back up to double digits!

I wonder when this is going to be finalised, any day soon I guess?

What's peoples thoughts?

Personally driving the SP up.

He's definitely all in on Genedrive, hopefully good things to come!

Unless there is some positive news on sales etc, I think this will slip back to 1p prior to the final raise RNS.

Question is do you but now or await the raise?

'The parties have indicated that they would be willing to proceed with the Equity Raise at, or around, the current share price (including higher)'

At the time of the RNS it was around 0.0083 to 0.0094 to buy

Just asked AI if Genedrive would still be required if a patient already had a full Genomic test...

Genedrive vs. Full Genomic Test

Genedrive Machine Test: This is a rapid, point-of-care molecular diagnostic device that tests for specific, limited genetic variants (e.g., the MT-RNR1 m.1555A>G variant that causes hearing loss with certain antibiotics). It provides results in approximately 26 minutes from a simple cheek swab, allowing clinicians to make immediate treatment decisions in time-critical situations, such as in a neonatal intensive care unit when a baby needs urgent antibiotics.

Full Genomic Test: A full genomic test, such as whole genome sequencing, looks at all or a large panel of an individual's genetic material. While it provides comprehensive information, the results typically take several days or weeks to process through a laboratory workflow.

Conclusion

A person who has had a full genomic test has the relevant genetic information, but the Genedrive machine might still be necessary if that specific result is needed immediately for an acute medical decision (e.g., in an emergency room) and the full genomic test results are not instantly accessible or available in a readily usable format at the bedside.

Pardon?

Is the SP going to up or down on this news...?

Hate to say it, but after observing this board for a few years, Slacker is generally not too far away with predictions... only saying!

Keeping an eye on this, was expecting an RNS to confirm loan had been signed. Must be still thrashing out the details under the heads of terms.

As always the devil is in the detail...

That's what I was thinking,... Bought in, agree loan terms, sign-up, sell accumulated shares at profit and within 12months at worst he owns the intellectual rights at a snip.

In the short term it is good news for shareholders, not all is lost.

Does anyone want to share a balanced view of what is next for GDR?

How long have they extended the cash runway for?

Will they achieve significant commercial traction in 2026 or is it going to be a funding crisis repeat in another few months?

For DN I think it is Win Win for him on both outcomes.

Just trying to gauge what people are thinking here?

Just a plan will do ;-)

What's peoples thoughts?

I personally thought that is it for GDR and have written my investment off, and rationalised it as a valuable lesson learnt, although financially painful.

Thinking of averaging down with the hope of getting to break even (if GDR survive), or is it too much of a risk?

High Risk / High Reward, if Genedrive can survive into a sustainable entity, hopefully they can generate funding without another huge dilution.

Trying to be optimistic

We need the leaders of health / medical organisations to change, which will take time. Until then there won't be a huge demand.